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Abstract Zfyl is a mouse Y chromosomal gene encoding a zinc 
finger protein which is thought to have some function during 
spermatogenesis. Here we show that, when introduced into tissue 
culture cells, Zfyl is targeted to the nucleus. Two independent 
signals are present within the protein for nuclear localization. 
This nuclear Zfyl protein is able to bind strongly to DNA-ceHu- 
lose and, using site-selection assays, we have identified specific 
Zfyl DNA binding sites. Taken together these results suggest 
that Zfyl is a nuclear-located sequence-specific DNA binding 
protein which functions during spermatogenesis. 
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1. Introduction 
The ZFY gene was originally identified as a human Y chro- 
mosomal gene that was a candidate for the testis-determining 
factor [1]. Although a primary role in sex determination has 
now been ruled out [2,3] the conservation of this gene on the 
Y chromosome of placental mammals suggests it has some 
important male-specific function, perhaps in spermatogenesis 
[4]. A gene closely related to ZFY, called ZFX, is also present 
on the X chromosome of all placental mammals o far analysed 
[4]. In mouse, however, this gene family is larger. Two genes, 
Zfyl and Zfy2, are present on the mouse Y chromosome [4], 
and an autosomal gene, Zfa, has been shown to be derived by 
retroposition of a transcript of Zfx [5]. Analysis of the sequence 
of several members of this gene family from several species [4,6] 
has revealed that they all encode proteins with thirteen repeats 
of the consensus equence for the zinc finger motif  [7,8]. 
The zinc finger is one of the structural motifs characteristic 
of DNA binding proteins [9]. It consists of a characteristic 
arrangement of cysteine and histidine residues which are 
thought to co-ordinate Zn 2+ ions. This maintains the finger 
structure which can interact with the major groove of DNA in 
a sequence-specific manner [10,11]. Large numbers of genes 
encoding zinc finger proteins (ZFPs) are present in eukaryotic 
genomes [12,13]. Some of these have been identified as tran- 
scription factors such as TF I I IA  [8] and Spl [14], developmen- 
tal genes in Drosophila such as Kruppel [15] and genes impli- 
cated as oncogenes [16,17] or tumour suppressor genes [18]. 
Many other ZFP genes have been isolated by low stringency 
hybridization or hybridization with consensus oligonucleotide 
probes [9,12,13,19]. Although the presence of zinc fingers is 
often taken to be indicative of a role in transcription, some 
ZFPs may have a structural role, while others may bind exclu- 
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sively to RNA and have functions in RNA storage or processes 
such as splicing. 
In order to analyse the properties of the ZFY family of zinc 
finger proteins, we have raised specific antibodies to murine 
Zfyl.  These have been used to demonstrate that Zfyl protein 
localizes to the nucleus of transfected cells and to identify spe- 
cific DNA binding sites for Zfyl ,  suggesting a role for this 
protein as a transcription factor regulating gene expression 
during spermatogenesis. 
2. Materials and methods 
2.1. Isolation of monoclonal ntibodies to Zfyl 
A 1.7 kb fragment encoding the C-terminal basic and zinc finger 
domains (residues 285 784) of Zfyl was amplified by PCR from the 
plasmid p955 [20] subcloned into the vector pRK171 [21] and intro- 
duced into E. coli bacterial strain BL21/DE3(pLysS). Electrophoresis 
of bacterial lysates on SDS-polyacrylamide gels revealed the induction 
by IPTG of a protein of 62 kDa, as predicted from the open reading 
frame of this part of Zfyl [20]. This C-terminal fragment of Zfyl was 
named ZfylC. The majority of the ZfylC protein was found to be 
insoluble and present in inclusion bodies in the bacteria. These were 
purified by centrifugation at 12,000 x g for 15 min at 4°C, solubilised 
in 1 M urea and the ZfylC protein purified by preparative gel electro- 
phoresis. The protein preparation was estimated tobe greater than 95% 
pure. 
To raise monoclonal antibodies to ZfylC, 70 pg of purified protein 
was used for each of two immunizations in CBH/Cbi rats. Spleen cells 
were fused to myeloma Y3 cells and hybridoma colonies grown under 
HAT selection [22]. Three positive hybridomas (MAbl4a, MAb25a and 
MAb79a) were obtained by screening by immunoblotting a ainst otal 
cell lysates of bacteria expressing Zfy 1C protein. These antibodies were 
typed as IgA (MAbl4a), IgG2b (MAb25a) and IgM (MAb79a). 
2.2. COS cell transfection a d immunofluorescence 
Full-length Zfyl cDNA and the various deletion mutants were 
cloned into the vector pcDNA I (Invitrogen) for expression in COS 
cells. Zfyl was tagged with the epitope (EQKLISEEDLN) of the Myc 
antibody 9E10 [23] using oligonucleotides inserted into the NcoI site 
corresponding to the initiating methionine. The protein A expression 
vector consisted of the human fl-globin 5" untranslated region and 
initiating methionine linked to the mature coding sequence of Staphylo- 
coccus aureus protein A from pRIT11 [24] cloned into the expression 
vector pCDM8 ([25] and S.S. and A.A., unpublished). COS cell trans- 
fection was as described by Aruffo et al. [25]. Transfection efficiency 
was in the range of 20~30%. For immunofluorescence th anti-Zfyl 
monoclonal MAb25a was used at a 1 : 50 dilution. Myc-epitope tagged 
proteins were stained with an anti-Myc monoclonal 9E10 [23] at 1:4 
dilution and protein A expression was detected by staining with an 
anti-protein A monoelonal antibody (Sigma) at a 1:100 dilution. A 
Nikon Optiphofluorescent microscope equipped with a Bio-Rad MRC 
600 confocal imaging system was used for visualisation. 
2.3. DNA cellulose column chromatography 
Nuclear extracts from COS cells transfected as described above were 
prepared as described by Lassar et al. [26] in buffer W (20 mM HEPES 
pH 7.6; 1.5 mM MgCI2; 0.1 mM EDTA; 0.5 mM ZnC12; 0.02% sodium 
azide; 1 mM DTT; 1 mM PMSF; 0.3 U/ml aprotinin; 5 pg/ml chy- 
mostatin; 10 pg/ml leupeptin; 5/tg/ml antipain; 5 pg/ml pepstatin A) 
containing 500 mM NaC1 and 0.1% Triton X-100. These were diluted 
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to 100 mM NaC1 in buffer W and then loaded through a fine needle 
at a rate of 100gl per minute onto a 5 cm long (0.5 cm diameter) column 
containing DNA cellulose in a SMART system (Pharmacia). The col- 
umn was then washed with lml of buffer W containing 100 mM NaC1. 
A step gradient of NaC1 was added up to 2 M NaC1. 50 gl fractions 
were assayed by Western blotting with the anti-Zfyl monoclonal nti- 
body MAb25a at 1 : 2,500 dilution followed by an anti-rat HRP conju- 
gated antibody at 1 : 7,500 dilution. The blot was developed using the 
ECL detection kit (Amersham). 
2.4. Identification of a DNA Binding Site for Zfyl 
Recombinant ZfylC protein was prepared for DNA binding by de- 
naturation i urea followed by renaturation [27]. The protein was first 
denatured in 1.5 x buffer Z (150 mM KC1, 37.5 mM HEPES, pH 7.9, 
1.5 mM DTT, 35 mM ZnSO4, 0.15% NP-40; 30% glycerol, 1.5 mM 
PMSF) with 6 M guanidine HC1 for 30 min at 4°C on a rotating wheel. 
The denaturant was slowly removed by dialysis against buffer Z with 
1 M guanidine HC1 for 3 h at 4°C. This was then repeated inbuffer Z 
but without guanidine HC1 to allow for gradual renaturation of the 
protein. 
Sequences binding to ZfylC were selected from a pool of double- 
stranded 76-mer oligonueleotides which contained a central region of 
26 random bp, flanked on either side by sequences of 25 bp each, which 
allowed recovery of small quantities of bound DNA by PCR amplifica- 
tion [28]. The sequences of these oligonucleotides were: Random se- 
quence 76-mer oligonucleotide (R76), 5'-CAGGTCAGATCAGCG- 
GATCCTGTCG(N)26GAGGCGAATTCAGTGCATGTGCAGC-3' , 
'Forward' primer, 5'-GCTGCACATGCACTGAATTCGCCTC-Y; 
'Back' primer, 5'-CAGGTCAGATCAGCGGATCCTGTCG-Y. Ran- 
dom oligonucleotide binding assays were performed essentially aspre- 
viously described [29,30]. Briefly, lug of purified renatured protein was 
electrophoresed on a 10% SDS-PAGE gel, electroblotted onto a nitro- 
cellulose filter and the filter incubated at 4°C with the 3~p-labelled pool 
of random oligonucleotides (107108 cpm/gg) prepared by primed 
synthesis [28]. After washing, the filters were autoradiographed and the 
area of the filter corresponding to bound DNA excised and the DNA 
eluted by heating to 100°C in water. Eluted DNA was amplified by 30 
cycles of PCR using 'forward' and 'back' primers, and the 76 bp prod- 
uct purified by agarose gel electrophoresis. For subsequent rounds of 
binding, the 76 bp product was labelled by 18 cycles of PCR in the 
presence of 32p-labelled nucleotide, as described [28]. DNA which re- 
mained bound to the ZfylC protein after the fourth round of selection 
was eluted, amplified, labelled and used in subsequent rounds of enrich- 
ment by electrophoretie mobility shift assays (EMSAs) [29]. Briefly, 
10 ng of purified, renatured ZfylC protein was pre-incubated in 20/21 
of binding buffer (10 mM HEPES, pH 7.9, 60 mM KC1, l mM DTT, 
1 mM EDTA, 0.25mg/ml bovine serum albumin and 12% glycerol) with 
1 pg poly(dl-dC) competitor DNA and 10 fmol (=20,000 cpm) of 
3zp-labelled, annealed oligonucleotides were added for 30 min at room 
temperature. The reactions were electrophoresed in non-denaturing 4%
acrylamide gels in 0.5 x TBE buffer at room temperature at 10 V/cm 
for 90 rain and the gels dried prior to autoradiography. The region of 
the dried gel containing DNA bound to the ZfylC protein in the 
presence of 1 gg poly(dI-dC) was heated at 100°C in water and the 
eluted DNA amplified as for the ROB assays. After a further five 
rounds of enrichment selection DNA was amplified as above, cloned 
into pBlueseript and the inserts from 23 clones equenced [31]. 
3. Results 
3.1. Zfy l  is located in the nucleus of  transfected tissue culture 
cells 
We expressed part of the coding sequence of murine Zfyl in 
E. coli under the control of a T7 polymerase r sponsive pro- 
moter. The 62 kDa protein produced, which contains the basic 
domain and the 13 C-terminal zinc fingers of Zfyl, was insolu- 
ble and located in inclusion bodies in the bacteria. Using cen- 
trifugation, solubilization i urea and preparative gel electro- 
phoresis we were able to isolate milligram quantities of the 
protein in essentially pure form (data not shown). Three mon- 
oclonal antibodies (Mab 14a, Mab25a nd Mab79a) were raised 
to this protein. These antibodies recognised Zfyl in both west- 
ern blots and ELISA assays (data not shown). We used these 
antibodies to investigate he subcellular location of Zfyl intro- 
duced into COS cells by transfection. A full-length eDNA clone 
coding for murine Zfyl  [20] was cloned into the mammalian 
expression vector pcDNA I in both sense and antisense orienta- 
tions and introduced by transfection into COS cells. The 
subcellular location of the Zfyl protein was determined by 
indirect immunofluorescence with the monoclonal antibody 
MAb25a. Clear nuclear staining was obtained in about 30% of 
cells transfected with an expression vector containing Zfyl  
(Fig. la (ii)) but not when the vector alone (Fig. la (iv)) was 
transfected. This reflects the approximately 30% transfection 
efficiency obtained. No staining was obtained if the Zfyl anti- 
body or the second antibody was omitted from the staining 
procedure (data not shown). Thus Zfyl protein is localised to 
the nucleus when expressed in COS cells. 
3.2. Two nuclear localization signals are present in Zfyl  
To determine which regions of Zfyl were responsible for 
nuclear targeting of the protein, we examined the sub-cellular 
location of deletion mutants of the protein. The Zfy family 
proteins appear to have a common modular structure com- 
posed of a large N-terminal acidic domain, a short basic region 
and the C-terminal zinc finger region [4]. By inspection the 
basic region located between amino acids 372 and 382 
(PKQKSKKKKR) shows some similarity to the SV40 nuclear 
localization signal PKKKRKV [32]. Part of Zfyl containing 
this sequence (amino acid residues 372-384) was fused to the 
C-terminus of protein A (construct e in Fig. lb) and the subcel- 
lular location of the protein determined by immunofluores- 
cence with an anti-protein A antibody. This demonstrated that 
this sequence could indeed behave as a functional nuclear local- 
ization signal. To determine if this sequence was necessary for 
nuclear localization of Zfyl, we introduced a 700 bp deletion 
into Zfyl (nucleotides 794-1497, amino acids 214-415). This 
construct (b in Fig. lb) was introduced into COS cells and the 
protein localized by immunofluoresence with the MAb25a. 
Surprisingly this construct also localized to the nucleus. Thus 
Zfyl contains two potentially functional nuclear localization 
signals. The cytoplasmic location of an N-terminal myc-tagged 
Zfyl fragment (construct d, Fig. lb) (amino acid residues 
1-214) demonstrated that the second nuclear localization is 
located in the zinc finger domain of Zfyl. 
3.3. Zfy l  is a DNA binding protein 
The presence of thirteen copies of the zinc finger motif within 
Zfyl suggested that this protein is capable of binding to DNA. 
To test this possibility, nuclear extracts were prepared from 
COS cells transfected with the full length Zfyl expression vec- 
tor described above. These extracts were chromatographed on 
double-stranded DNA (dsDNA) cellulose columns in a 
SMART system (Pharmacia) (Fig. 2). The SMART system 
allows chromatography of small amounts of protein with min- 
imal losses. After loading, the column was washed extensively 
with buffer W containing 100 mM NaC1. The column was 
developed by the application of a stepwise NaC1 gradient and 
column fractions analysed by electrophoresis on SDS/poly- 
acrylamide gels and immunoblotting with antibodies against 
Zfyl. The Zfyl protein bound to the dsDNA column and was 
eluted as tight peak at about 350 mM NaC1 (Fig. 2). This 
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Fig. 1. Nuclear Localisation of Zfyl expressed in COS cells. (a) Indirect immunofluorescence staining of COS cells some of which are xpressing 
Zfyl protein. COS cells were grown on coverslips, transfected with a Zfyl expression vector (i and ii) or the expression vector alone (iii and iv) and 
after 3 days were stained with anti-Zfyl monoclonal ntibody Mab25a (ii and iv). Parts i and iii show the stained cells as viewed by phase contrast 
microscopy. (b) Structure and subcellular localization of Zfyl expression constructs. Expression vectors carrying various parts of Zfy 1 either unfused, 
fused with protein A or tagged with the myc 9El0 antibody epitope were transfected into COS cells. The cells were fixed and the expressed protein 
localised by indirect immunofluorescence with the appropriate antibody. Constructs are as described in sections 2 and 3. Zfyl has been divided into 
three domains as described previously [4]. 
indicates that Zfyl expressed in vivo has bona fide DNA bind- 
ing activity. 
3.4. Identification of a DNA binding site for Zfyl 
The demonstration that Zfyl had dsDNA binding properties 
typical of a DNA binding protein led us to investigate whether 
this protein bound DNA sequence specifically. Recombinant 
Zfy lC protein was purified by preparative gel electrophoresis, 
then denatured and re-folded in the presence of zinc cations and 
used in random oligonucleotide binding assays [30]. Oligonucle- 
otides bound to the Zfyl protein were eluted and amplified by 
PCR, then used in further ounds of binding, elution a d ampli- 
fication, to select for sequences that bound specifically. After 
four rounds of selection, the DNA was used in a further five 
rounds of enrichment by the electrophoretic mobility shift 
assay (EMSA). After the final round of selection the eluted 
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Fig. 2. DNA binding Properties of Zfy-1 Expressed in COS cells. (a) Fractionation of COS cell extracts on DNA cellulose. Trace A: spectrophotom- 
etric readout a OD2g0 of fractious eluted from the DNA cellulose column. Trace B: NaC1 concentration applied to the DNA cellulose column in 
a step gradient fashion. Trace C: Th salt concentration of fractions eluted from the column. (b) Immunoblot of the fractions eluted from the DNA 
cellulose column. These were electrophoresed through a SDS-polyaerylamide gel, blotted onto nitrocel uloseand probed with anti-Zfy-1 antibody. 
Fractions are as in part a. Cytoplasmic Fraction and Nuclear Pellet are sub-cellular fractions prepared as described insection 2. Nuclear Dilution 
Pellet corresponds to nuclear extract diluted to 100 mM NaC1 prior to loading on the gradient: 
DNA was amplified, cloned and individual sub-clones e- 
quenced. The sequences of individual clones and consensus 
sequences are shown in Fig. 3. Of the 23 clones analysed 20 
contained a sequence corresponding to one of three categories 
of DNA binding sequence. The other 3 contained no detectable 
homology. This large enrichment for the motifs underlined in 
Fig. 3 demonstrates that we have isolated at least part of a 
specific binding site for Zfyl. All the selected sequences in 
Fig. 3 contain at least one and in some cases (class I) two copies 
of the core sequence AGGCC, suggesting that that this may be 
crucial for DNA binding. 
4. Discussion 
Zfyl  is a zinc finger protein encoding ene located on the 
mouse Y chromosome. Although previously thought o have 
a function in testis determination, such a role has now been 
excluded [1-3]. It has been suggested that the Zfyl  gene may 
have a function in spermatogenesis, perhaps as a transcription 
factor [4]. Here we examine the subcellular localisation and 
DNA binding potential of this protein. In initial studies we 
attempted todetermine the subcellular location of endogenous 
Zfyl but we were unable to detect he protein in male mouse 
germ cells by immunofluorescence. We therefore xpressed 
Zfyl in COS cells and demonstrated that the protein was lo- 
cated in the nucleus of the transfected cells. We went on to show 
that a previously recognised region of Zfyl homologous to the 
SV40 T antigen nuclear localisation signal [20,33] is indeed 
capable of targeting a heterologous protein to the nucleus. 
However this was shown to be dispensable for Zfyl nuclear 
localisation as a deletion mutant lacking this sequence was also 
located in the nucleus. It is possible that this second signal is 
cryptic and revealed only when the normally utilised sequence 
is removed. This redundancy may be common as several other 
proteins have been described which ontain multiple nuclear 
localisation signals; the yeast repressor a2 has two non-homol- 
ogous signals, one located at the N terminus as well as one in 
the homeodomain [34]. 
As Zfyl appears to be a nuclear protein and contains zinc 
finger motifs characteristic of nucleic acid binding proteins, we 
decided to examine the DNA binding potential of the protein. 
We used transient transfection and DNA-cellulose chromatog- 
raphy of nuclear extracts to demonstrate hat Zfyl expressed 
in vivo was capable of binding to DNA with binding character- 
istics typical of bona fide DNA binding proteins. In order to 
determine whether this binding was specific or non-specific we 
utilised site-selection assays to define DNA binding sites for 
Zfyl. The similarity of the selected sequences suggested that we 
had indeed identified specific binding sites. The specificity has 
been confirmed by the use of band shift assays (data not 
shown). The identification of distinct but related groups of 
sequences may reflect he binding of zinc fingers as independent 
modules [10,11]. 
The possibility that Zfyl interacts with a longer DNA bind- 
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4REV 
7REV 
I 13FOR 
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2REV 
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18REV 
19REV 
20REV 
IFOR 
5FOR 
8FOR 
3 IIREV 
15FOR 
16FOR 
22REV 
24FOR 
cagoggatcctgtcgATGGAGGCCCGA~TAGGCCTAAAATTgaggcgaattca 
cagcggatcctgccgATGTAGGCCCGAGTAG~CCTAAAATTgaggcgaattca 
cagcggatcctgtcgATGGAGGCCCGAGTAGGCCTAAAATTgaggcgaattc 
cagcggatcctgtcgATTGAGGCCCGA~TAGGCCTAAAATTcaggcgaattc 
cactgaattcgcctcAATATAAGAAATGGCCC TTTAGGCCTcgacaggatctg 
ggatcctgtcgGCCTTAAGTTTCTCTAGGCCCAAAAAgaggcgaattc 
gaattcgcctcGTTAGGAAATGAAGGCCCAAGCCTACcgacaggatcc 
gaattcgcctcTTAGGCCCATAGGCAACTTGAAAATcgacaatcgaatt  
gaattcgcctcGCAGGCCCGCCAATACTAAACATCAAcggcaggatccgC 
gaattcgcctcATTCATCAATAGCAGGCCCAAGTCTCcgataggatcc 
gaattcgcctcTCTAGGAAATGAA~CCCAAGCCTACcgacaggatccgc 
ggatcctgtcgAATAGTAGGCCCGACTGCGTCCTTTACTgaggcgaattc 
gaattcgcctcTAGGCCAAAGCGCAATGTTACGAAATcgacaggatccgc 
gaattcgcctCTATGGCCTACTAAAAGTAACTcgacaggatc 
gaattcgcctcCTAACAAGGCCAAAGGCTACTTTCCcgacaggatc 
gaattcgcctcTAC~ACTAGGCCAAAAACTCGATTAAcgacaggatcc 
gaattcgcctcAAATTACTAGGCCACGACATTGCTCAcgacaggatcc 
actgaattcgcctcTAGGTTTTGGCCTACCCAATTGATTTcgacaggatcc 
ggatcctgtcgTAATAGTAGGCCGACTGCGTCCTTACTgaggcgaattC 
tCtcgTAACATTGCGCTTTGGCCTAgaggcgaattC 
Fig. 3. Sequence of oligonucleotides s lected by Zfyl. Recombinant Zfyl C was used in site-selection assays to isolate specific DNA binding sites from 
a pool of random oligonucleotides. These were cloned and sequenced. The sequences shown have been divided into three classes based on sequence 
homology and the homologous regions underlined. 
ing site of which we have identified part could be addessed by 
utilising the binding site already identified in combination with 
a further round of site selection to 'bootstrap' to a longer and 
presumably higher affinity site. Alternatively the identification 
of a bona fide in vivo binding site for Zfyl should allow char- 
acterisation of an extended binding site. Interestingly, a se- 
quence related to the site selected sequences identified here is 
found at the 5' end of the Zfx gene [35]. Recently we have been 
able to show that Zfyl can bind to this sequence in gel mobility 
shift assays (data not shown) and this suggests the intriguing 
possibility that Zfyl may be able to trans-regulate he expres- 
sion of the Zfx gene in vivo. 
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